Mar 25, 2024

OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for $2 billion

Sep 14, 2022

New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals

Nov 20, 2019

Study of Ontario health data offers new directions in sarcoma research and treatment

Nov 18, 2019

Potential new approach to T-cell therapy shows early promise in the lab

Sep 30, 2019

Hamilton study discovers new approach to target cells at the root of leukemia

Sep 10, 2018

Researchers find unexpected cells at the centre of recurrent leukemia

Aug 02, 2018

Ontario centre attracts national attention for probe research, development and commercialization

Apr 09, 2018

Biostatistics Training Initiative boosts Ontario's cancer research community

Dec 04, 2017

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Oct 20, 2017

Old drug, new trick: study finds common diabetes drug could help fight leukemia

Oct 11, 2017

Ontario start-up makes major deal to develop cancer-fighting viruses

Sep 06, 2017

Innovative study brings next-generation genomic sequencing to more Ontario cancer patients

Aug 17, 2017

New genes discovered regulating brain metastases in lung cancer

May 03, 2017

Study bringing more precision medicine to Ontario’s cancer patients

Apr 26, 2017

Clinical trial opens for promising combination therapy

Aug 17, 2016

New retrospective study aims to identify mutations to better diagnose breast cancer in the future

Jul 04, 2016

OICR congratulates Drs. Mark Levine, Eduardo L. Franco and Gerald Batist, new recipients of the Order of Canada

Jun 01, 2016

Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management

May 05, 2016

A new method to grow stem cells for cancer patients

Mar 16, 2016

FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic

Feb 26, 2016

Biostatistics Training Initiative Kick Off

Dec 16, 2015

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

Nov 09, 2015

FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership